Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Vivanza Biosciences Ltd

NSE: VIVANZA · BSE: 530057 · Pharmaceuticals & Biotechnology · 20 announcements

Share price
₹1.70
Market cap
₹6.80 Cr
Revenue (annual)
₹115.9 Cr
Net profit (annual)
₹0.39 Cr
P/E (TTM)
15.0×Sector 47.3×
Promoter holding
20.02%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:08 IST BSE
Board Meeting Date

Vivanza Biosciences Board Meeting Date

Vivanza Biosciences has scheduled a board meeting for August 17, 2026, to discuss the AGM, financial reports, and various corporate authorizations under the Companies Act.

17:52 IST BSE
Board Meeting Date

Vivanza Biosciences Board Meeting Date

Vivanza Biosciences has scheduled a board meeting on August 01, 2026, to consider and approve the standalone and consolidated financial results for the quarter ended June 30, 2026.

11:43 IST BSE
Board Meeting Date

Vivanza Biosciences Board Meeting Date

Vivanza Biosciences announced the Board meeting scheduled for 18 June 2026. The meeting will consider auditor appointment, director nomination and share transfer matters.

15:09 IST BSE
Board Meeting Date

Vivanza Biosciences Board Meeting Date

Vivanza Biosciences Limited has rescheduled its Board Meeting to May 7, 2026, to approve audited financial results for the quarter and year ended March 31, 2026. The meeting was originally planned for May 4, 2026. The trading window will remain closed until 48 hours after the results declaration.

14:24 IST BSE
Board Meeting Date

Vivanza Biosciences Board Meeting Date

Vivanza Biosciences Ltd has scheduled a Board of Directors meeting on May 04, 2026. The board will consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The company's trading window remains closed until 48 hours after the results declaration.